Ai Nile Inc

Ai Nile Inc specializes in medication reminder application software, which helps users manage prescribed treatment plans through automated alerts and tracking features. These are software-based solutions designed for personal use on mobile devices, ensuring patients stay on schedule with their medication routines.

Ai Nile Inc is based in the United States, where its software-based devices are authorised for commercial distribution. The company’s location aligns with FDA regulatory oversight, as its products fall under the FDA’s jurisdiction for software-as-a-medical-device (SaMD) classification.

Ai Nile Inc’s devices are listed in the FDA’s Unique Device Identifier (UDI) database, which is a centralised registry for tracking medical devices authorised in the US. This inclusion ensures transparency and traceability for regulatory and market surveillance purposes.

Ai Nile Inc’s medication reminder applications are classified as FDA Class I devices. This classification is typically assigned to low-risk products, including software that poses minimal risk to patients when used as intended—such as automated reminders for medication adherence—without active patient monitoring or complex interventions.